| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |